Log In
Print this Print this

ORT-VAC DNA TB vaccine

  Manage Alerts
Collapse Summary General Information
Company Recipharm AB
DescriptionSalmonella-based oral ORT-VAC DNA vaccine expressing the Myobacterium tuberculosis antigen MPT64
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: DNA vaccine
Latest Stage of DevelopmentPreclinical
Standard IndicationTuberculosis
Indication DetailsVaccinate against tuberculosis (TB)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today